This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Pediatrics  • Pediatrics, Other  • Quality of Care  • Patient Safety/ Medical Error  • Drug Therapy  • Adverse Effects  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Bridget M. Kuehn

JAMA. 2008;300(20):2354-2356.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In the wake of calls for the US Food and Drug Administration (FDA) to discourage the use of cold and cough medicines for children younger than 6 years, the makers of such products have agreed to change the products’ labels, the second labeling change in about a year.

Many pediatricians advise parents to use such proven therapies as humidification rather than cold medicines to treat children with colds. (Photo credit: AJPhoto/www.sciencesource.com)

In October, the Consumer Healthcare Products Association (CHPA), a group that represents the manufacturers of over-the-counter cold and cough products, announced that its members would voluntarily revise the labels of children's cold and cough medicines to indicate that the products should not be used in children younger than 4 years. The group also added a warning to the label of products containing antihistamines that they should not be used to sedate children.

The announcement . . . [Full Text of this Article]

WIDELY USED



CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?